103 related articles for article (PubMed ID: 16989287)
21. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
24. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells.
Thompson HG; Harris JW; Wold BJ; Lin F; Brody JP
Oncogene; 2003 Apr; 22(15):2322-33. PubMed ID: 12700667
[TBL] [Abstract][Full Text] [Related]
25. A short region of the promoter of the breast cancer associated PLU-1 gene can regulate transcription in vitro and in vivo.
Catteau A; Rosewell I; Solomon E; Taylor-Papadimitriou J
Int J Oncol; 2004 Jul; 25(1):5-16. PubMed ID: 15201984
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 2 regulates bone sialoprotein gene transcription in human breast cancer cells.
Li Z; Wang Z; Yang L; Li X; Sasaki Y; Wang S; Araki S; Mezawa M; Takai H; Nakayama Y; Ogata Y
J Oral Sci; 2010 Mar; 52(1):125-32. PubMed ID: 20339243
[TBL] [Abstract][Full Text] [Related]
27. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts.
Tseng L; Tang M; Wang Z; Mazella J
DNA Cell Biol; 2003 Oct; 22(10):633-40. PubMed ID: 14611684
[TBL] [Abstract][Full Text] [Related]
28. Regulation of a promoter of the fibroblast growth factor 1 gene in prostate and breast cancer cells.
Payson RA; Chotani MA; Chiu IM
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):93-103. PubMed ID: 9719443
[TBL] [Abstract][Full Text] [Related]
29. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
[TBL] [Abstract][Full Text] [Related]
30. Two promoters regulate transcription of the mouse folylpolyglutamate synthetase gene three tightly clustered Sp1 sites within the first intron markedly enhance activity of promoter B.
Chen J; Hayes P; Roy K; Sirotnak FM
Gene; 2000 Jan; 242(1-2):257-64. PubMed ID: 10721719
[TBL] [Abstract][Full Text] [Related]
31. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
32. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21
Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):761-774. PubMed ID: 29032246
[TBL] [Abstract][Full Text] [Related]
34. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
[TBL] [Abstract][Full Text] [Related]
35. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
36. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin.
Hesselbrock DR; Kurpios N; Hassell JA; Watson MA; Fleming TP
Breast Cancer Res Treat; 2005 Feb; 89(3):289-96. PubMed ID: 15754128
[TBL] [Abstract][Full Text] [Related]
37. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
40. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
Hong C; Kim HA; Firestone GL; Bjeldanes LF
Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]